Interferon alpha and 13 cis retinoid acid in the therapy of metastatic renal cell carcinoma.

被引:0
|
作者
Ostrizkova, L [1 ]
Kocak, I [1 ]
Palacova, M [1 ]
Kebedeova, D [1 ]
机构
[1] Masaryk Mem Canc Inst, Brno, Czech Republic
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
359
引用
收藏
页码:81 / 81
页数:1
相关论文
共 50 条
  • [41] ASSESSING INTERFERON-ALPHA MONOTHERAPY IN PATIENTS WITH ADVANCE OR METASTATIC RENAL CELL CARCINOMA
    Rai, M. K.
    Nair, S. R.
    McEwan, P.
    VALUE IN HEALTH, 2010, 13 (07) : A252 - A252
  • [42] EFFICACY OF RECOMBINANT ALPHA-INTERFERON-2A AND 13-CIS-RETINOIC ACID IN THE TREATMENT OF SQUAMOUS-CELL CARCINOMA
    TOMA, S
    PALUMBO, R
    VINCENTI, M
    AITINI, E
    PAGANINI, G
    PRONZATO, P
    GRIMALDI, A
    ROSSO, R
    ANNALS OF ONCOLOGY, 1994, 5 (05) : 463 - 465
  • [43] Maximal COX-2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinoma
    Rini, BI
    Weinberg, V
    Dunlap, S
    Elchinoff, A
    Yu, N
    Bok, R
    Simko, J
    Small, EJ
    CANCER, 2006, 106 (03) : 566 - 575
  • [44] Floxuridine (FUDR) plus interferon α2A (IFN 2A) plus 13-cis-retinoic acid (CRA) in metastatic renal cell carcinoma (MRCC)
    Cianci, C
    Antonuzzo, A
    Falcone, A
    Galli, L
    Ricci, S
    Sacco, C
    Cartei, G
    Bertuccelli, M
    Taviani, R
    Conte, PF
    ANNALS OF ONCOLOGY, 1998, 9 : 63 - 63
  • [45] INVESTIGATIONAL THERAPY OF RENAL-CELL CARCINOMA WITH RECOMBINANT ALPHA-INTERFERON
    QUESADA, JR
    GUTTERMAN, JU
    RIOS, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 195 - 195
  • [46] 13-cis-retinoic acid and interferon-alpha 2a as palliative therapy of pretreated, recurrent squamous cell carcinoma of the uterine cervix and vulva
    Romisch, M
    Meier, W
    Kimmig, R
    Hepp, H
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1996, 56 (10) : 520 - 524
  • [47] 13-CIS-RETINOIC ACID PLUS INTERFERON ALPHA-2A - HIGHLY-ACTIVE SYSTEMIC THERAPY FOR SQUAMOUS-CELL CARCINOMA OF THE CERVIX
    LIPPMAN, SM
    KAVANAGH, JJ
    PAREDESESPINOZA, M
    DELGADILLOMADRUENO, F
    PAREDESCASILLAS, P
    HONG, WK
    HOLDENER, E
    KRAKOFF, IH
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (04): : 241 - 245
  • [48] Dendritic cell vaccine: A potential treatment for metastatic renal cell carcinoma.
    Tanguay, S
    Chagnon, F
    Bergeron, F
    Aprikian, AG
    Gervais, F
    JOURNAL OF UROLOGY, 1998, 159 (05): : 148 - 148
  • [49] Phase II trial of pegylated Interferon alpha-2b, GM-CSF and thalidomide in metastatic progressive renal cell carcinoma.
    Sawhney, R
    Brescia, F
    Keane, T
    Clarke, H
    Chaudhary, UB
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 452S - 452S
  • [50] PHASE-II STUDY OF ALPHA-INTERFERON AND 13-CIS-RETINOIC ACID IN METASTATIC MELANOMA
    DHINGRA, K
    PAPADOPOULOS, N
    LIPPMAN, S
    LOTAN, R
    LEGHA, SS
    INVESTIGATIONAL NEW DRUGS, 1993, 11 (01) : 39 - 43